Ā Third vaccine reduces critical response to covid in patients with cirrhosisĀ
Booster shots reduce severity of covid in cirrhosis patients
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Booster shots reduce severity of covid in cirrhosis patients
October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a āuniversalā method of treating Covid-19. According to.
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.
Scientists are hopeful of an mRNA based vaccine for cancer
The global response to combat the Covid-19 crisis lacked cooperation and coordination: WHO
Immune evasive BQ! strains spreading fast in the US and European countries
Modernaās mRNA vaccine is being studied in combination with Merckās Keytruda to treat patients with high-risk melanoma
Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial
COVID-19 vaccine maker BioNTech inks research deal with Australia
Recurring global deadly disease outbreaks crippling economies